Diagnostic Protein induced by vitamin K absence-II (PIVKA-II) antibodies (anti-Protein induced by vitamin K absence-II, anti-PIVKA-Ⅱ) for Tumor/Cancer PIVKA-Ⅱ detection in ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
Catalog Number: GMP-PIVKA-II-Ab
Protein induced by vitamin K absence-II (PIVKA-II) is a potential screening marker for hepatocellular carcinoma (HCC).
Protein induced by vitamin K absence-II (PIVKA-II), also known as des-γ-carboxy-prothrombin, has been identified as a serum biomarker linked to HCC. It is an abnormal prothrombin molecule produced as a consequence of an acquired defect in the posttranslational carboxylation of the prothrombin precursor in malignant cells. A quite large body of evidence indicates that PIVKA-II levels in the blood are increased in patients with HCC and importantly, an increasing amount of data indicates that it is more sensitive than AFP for differentiating HCC at all stages from patients with cirrhosis or chronic hepatitis. In addition, several studies from Asian countries have shown that serum PIVKA-II levels correlate with the HCC stage, as well as with survival of HCC patients, and a combination of PIVKA-II and AFP is currently used in Japan for HCC diagnosis and surveillance in accordance with the recommendations of the Clinical Practice Guidelines for HCC of that country.
Genemedi produces core diagnostic ingredients for test of Tumor/Cancer and related syndrome.
GeneMedi offers paired diagnostics grade Protein induced by vitamin K absence-II (PIVKA-Ⅱ) ) antibodies (monoclonal antibody, mab) and Protein induced by vitamin K absence-II (PIVKA-Ⅱ) ) antigens for Tumor/Cancer rapid test kit of Protein induced by vitamin K absence-II (PIVKA-Ⅱ) ) testing in ELISA test,Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
All the antibodies and antigens for Tumor/Cancer test are suitable for in functional ELISA, and other immunoassays in dignostics.The antibodies can act as a capture antibody and detection antibody.The antigens can be used for antibodies rapid test of Tumor/Cancer.
Order information
Catalog No. | Size | Price(In USD) | Qty (Quantity) | Sum(In USD) |
---|---|---|---|---|
GMP-PIVKA-II-Ab-1 | Size:1mg | 1953 | ||
GMP-PIVKA-II-Ab-1 | Size:10mg | 13671 | ||
GMP-PIVKA-II-Ab-1 | Size:100mg | 95697 | ||
GMP-PIVKA-II-Ab-2 | Size:1mg | 1953 | ||
GMP-PIVKA-II-Ab-2 | Size:10mg | 13671 | ||
GMP-PIVKA-II-Ab-2 | Size:100mg | 95697 | ||
GMP-PIVKA-II-Ab | ≥100mg | Inquiry | ||
Shipping Cost: | 760.00 | |||
Total: | ||||
Description
Cat No. | GMP-PIVKA-II-Ab-1; GMP-PIVKA-II-Ab-2 |
Product Name | Anti-Protein induced by vitamin K absence-II (PIVKA-II) mouse monoclonal antibody(mAb) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Human Protein induced by vitamin K absence-II (PIVKA-II) protein binding, ELISA validated as capture antibody and detection antibody. Pair in PIVKA-II level test and Tumor/Cancer evaluation. |
Tag | mFc |
Products description | Anti-Protein induced by vitamin K absence-II (PIVKA-II) mouse monoclonal antibody(mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Specics | mouse |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
- GENEMEDI
- Email: [email protected] [email protected]
- Telephone: +86-21-50478399 Fax: 86-21-50478399
- Privacy Policy
- TECHNICAL SUPPORT
- Product FAQs
- Technical manuals
- Publications
- Email: [email protected]